{"prompt": "['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 69 of 128', 'Panel 10: Description of the severity of each IGA sign or symptom', 'Sign/symptom', 'Severity', 'Description of severity', 'Erythema', 'Mild', 'Faint erythema', 'Moderate', 'Prominent redness', 'Severe', 'Deep intense red colour', 'Scaling', 'Mild', 'Slight flaking, mostly fine scales', 'Moderate', 'Flaking, thicker scales', 'Severe', 'Desquamation with thick scales', 'Lichenification /', 'Mild', 'Mild thickening with exaggerated skin lines', 'hyperkeratosis', 'Moderate', 'Palpable thickening', 'Severe', 'Prominent thickening with exaggeration of normal skin markings', 'Vesiculation', 'Mild', 'Scattered vesicles, without erosion', 'Moderate', 'Clustered vesicles, without visible erosion or excoriation', 'Severe', 'High density of vesicles, or with erosion or excoriation', 'Oedema', 'Mild', 'Slight dermal swelling', 'Moderate', 'Definite dermal swelling', 'Severe', 'Dermal swelling with skin induration', 'Fissures', 'Mild', 'Superficial fissures', 'Moderate', 'Definite fissures', 'Severe', 'One or more deep fissures with/without bleeding', 'Inspired by Ruzicka et al (11) and Fowler JF (personal communication, 09 May 2017). The term Physician', 'Global Assessment was used by Ruzicka/Fowler, but IGA will be used in this trial.', '11.3.2 Hand Eczema Severity Index (HECSI)', 'The HECSI is an instrument used in clinical trials to rate the severity of 6 clinical signs', '(erythema [E], infiltration/papulation [I], vesicles [V], fissures [F], scaling [S], oedema [O])', 'and the extent of the lesions on each of the 5 hand areas (fingertips, fingers [except', 'fingertips], palm of hands, back of hands, and wrists) by use of standard scales (13).', 'For each hand area (total of both hands e.g., 10 fingers), the investigator rates the average', 'severity of each of the 6 clinical signs of hand eczema using a 4-point severity scale ranging', 'from 0 (none/absent) to 3 (severe) (Panel 11). The investigator also rates the extent of the', 'lesions by assessing the percentage of the areas these lesions occupy, and converting it to a']['Trial ID: LP0133-1273', 'Date: 07-Dec-2018', 'Version: 3.0', 'Page 70 of 128', 'score based on a 5-point scale (the affected area score [AS]) (Panel 11). For each of the hand', 'areas, the grades for 6 selected clinical signs of hand eczema are totalled (E + I + V + F + S +', 'O = total grade) and this total grade will be multiplied by the converted affected AS based on', 'the area of both hands (Panel 12). The highest possible HECSI score is 360.', 'The HECSI will be assessed at time points according to the schedule of trial procedures', '(Section 4). The assessment will be based on the condition of the disease at the time of', 'evaluation and not in relation to the condition at a previous visit. New lesions that occurred on', 'previously untreated areas will be included in the assessment.', 'Panel 11: HECSI severity score scale and area score scale', 'Severity score (SS) scale', 'Area score (AS) scale', '(based on both hands)', '(based on the area of both hands)', '0', 'None/absent', '0', '0% affected area', '1', 'Mild', '1', '1% to 25% affected area', '2', 'Moderate', '2', '26% to 50% affected area', '3', 'Severe', '3', '51% to 75% affected area', 'Note: half-steps (0.5, 1.5, 2.5) are not allowed.', '4', '76% to 100% affected area', 'Note: half-steps (0.5, 1.5, 2.5, 3.5) are not allowed.', 'Panel 12: Calculation of the total HECSI score', 'Hand region', 'Fingertips', '(SS +', 'SS +', 'SS +', 'SS +', 'SS +', 'SS )', 'x AS', 'Fingers (except', '(SS +', 'SS +', 'SS +', 'SS +', 'SS +', 'SS)', 'AS', 'fingertips)', 'Palm of hands', '( SS +', 'SS +', 'SS +', 'SS +', 'SS +', 'SS) )', 'X AS', 'Back of hands', '(SS +', 'SS +', 'SS +', 'SS +', 'SS +', 'SS) )', 'x AS', 'Wrists', '(SS+', 'SS +', 'SS +', 'SS +', 'SS +', 'SS)', 'X AS', 'The total HECSI score equals the sum of the 5 above region scores:', 'AS, area score; SS, severity score.']\n\n###\n\n", "completion": "END"}